000 01250 a2200289 4500
005 20250514021731.0
264 0 _c20020416
008 200204s 0 0 eng d
022 _a0962-8436
024 7 _a10.1098/rstb.2001.0982
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBelshe, R B
245 0 0 _aSafety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
_h[electronic resource]
260 _bPhilosophical transactions of the Royal Society of London. Series B, Biological sciences
_cDec 2001
300 _a1947-51 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Meta-Analysis
650 0 4 _aAdministration, Intranasal
650 0 4 _aAdult
650 0 4 _aChild, Preschool
650 0 4 _aHumans
650 0 4 _aInfluenza Vaccines
_xpharmacology
650 0 4 _aInfluenza, Human
_ximmunology
650 0 4 _aVaccines, Attenuated
_xpharmacology
700 1 _aGruber, W C
773 0 _tPhilosophical transactions of the Royal Society of London. Series B, Biological sciences
_gvol. 356
_gno. 1416
_gp. 1947-51
856 4 0 _uhttps://doi.org/10.1098/rstb.2001.0982
_zAvailable from publisher's website
999 _c11691198
_d11691198